130 related articles for article (PubMed ID: 21335936)
1. Prevalence and outcome of absence of ductus venosus at 11(+0) to 13(+6) weeks.
Staboulidou I; Pereira S; Cruz Jde J; Syngelaki A; Nicolaides KH
Fetal Diagn Ther; 2011; 30(1):35-40. PubMed ID: 21335936
[TBL] [Abstract][Full Text] [Related]
2. Ductus venosus blood flow assessment at 11 to 14 weeks of gestation and fetal outcome.
Toyama JM; Brizot ML; Liao AW; Lopes LM; Nomura RM; Saldanha FA; Zugaib M
Ultrasound Obstet Gynecol; 2004 Apr; 23(4):341-5. PubMed ID: 15065182
[TBL] [Abstract][Full Text] [Related]
3. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects].
Baś-Budecka E; Perenc M; Sieroszewski P
Ginekol Pol; 2010 Apr; 81(4):272-6. PubMed ID: 20476599
[TBL] [Abstract][Full Text] [Related]
4. Abnormal first-trimester ductus venosus blood flow: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency.
Martínez JM; Comas M; Borrell A; Bennasar M; Gómez O; Puerto B; Gratacós E
Ultrasound Obstet Gynecol; 2010 Mar; 35(3):267-72. PubMed ID: 20052662
[TBL] [Abstract][Full Text] [Related]
5. A mixture model of ductus venosus pulsatility index in screening for aneuploidies at 11-13 weeks' gestation.
Maiz N; Wright D; Ferreira AF; Syngelaki A; Nicolaides KH
Fetal Diagn Ther; 2012; 31(4):221-9. PubMed ID: 22614037
[TBL] [Abstract][Full Text] [Related]
6. Abnormal first-trimester ductus venosus blood flow: a risk factor for adverse outcome in fetuses with normal nuchal translucency.
Oh C; Harman C; Baschat AA
Ultrasound Obstet Gynecol; 2007 Aug; 30(2):192-6. PubMed ID: 17518423
[TBL] [Abstract][Full Text] [Related]
7. Screening performances of abnormal first-trimester ductus venosus blood flow and increased nuchal translucency thickness in detection of major heart defects.
Karadzov-Orlic N; Egic A; Filimonovic D; Damnjanovic-Pazin B; Milovanovic Z; Lukic R; Mandic V; Joksic I; Vukomanovic V; Kosutic J; Djuricic S; Mikovic Z
Prenat Diagn; 2015 Dec; 35(13):1308-15. PubMed ID: 26408089
[TBL] [Abstract][Full Text] [Related]
8. [Prospective cohort study of fetal nuchal translucency in first-trimester and pregnancy outcome].
Tang HR; Zhang Y; Ru T; Li J; Yang L; Xu Y; Duan HL; Wang Y; Wang Y; Hu YL; Zhang Y; Zheng MM
Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):94-99. PubMed ID: 32146737
[No Abstract] [Full Text] [Related]
9. The role of ductus venosus Doppler flow in the diagnosis of chromosomal abnormalities during the first trimester of pregnancy.
Florjański J; Fuchs T; Zimmer M; Homola W; Pomorski M; Blok D
Adv Clin Exp Med; 2013; 22(3):395-401. PubMed ID: 23828681
[TBL] [Abstract][Full Text] [Related]
10. First-trimester detection of major cardiac defects with the use of ductus venosus blood flow.
Borrell A; Grande M; Bennasar M; Borobio V; Jimenez JM; Stergiotou I; Martinez JM; Cuckle H
Ultrasound Obstet Gynecol; 2013 Jul; 42(1):51-7. PubMed ID: 23152003
[TBL] [Abstract][Full Text] [Related]
11. Umbilical cord diameter at 11-14 weeks of gestation: relationship to nuchal translucency, ductus venous blood flow and chromosomal defects.
Axt-Fliedner R; Schwarze A; Kreiselmaier P; Krapp M; Smrcek J; Diedrich K
Fetal Diagn Ther; 2006; 21(4):390-5. PubMed ID: 16757918
[TBL] [Abstract][Full Text] [Related]
12. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness.
Maiz N; Plasencia W; Dagklis T; Faros E; Nicolaides K
Ultrasound Obstet Gynecol; 2008 Mar; 31(3):256-60. PubMed ID: 18307193
[TBL] [Abstract][Full Text] [Related]
13. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks.
Karadzov-Orlić N; Egić A; Filimonović D; Marinković M; Damnjanović-Pazin B; Milovanović Z; Joksić I; Branković S; Lukić R; Mandić V; Cerović N; Mojović D; Plamenac S; Stanković M; Maglić D; Mikovć Z
Srp Arh Celok Lek; 2012; 140(9-10):606-11. PubMed ID: 23289277
[TBL] [Abstract][Full Text] [Related]
14. First-trimester ductus venosus velocimetry in relation to nuchal translucency thickness and fetal karyotype.
Zoppi MA; Putzolu M; Ibba RM; Floris M; Monni G
Fetal Diagn Ther; 2002; 17(1):52-7. PubMed ID: 11803218
[TBL] [Abstract][Full Text] [Related]
15. Low-resistance hepatic artery flow in first-trimester fetuses: an ominous sign.
Bilardo CM; Timmerman E; De Medina PG; Clur SA
Ultrasound Obstet Gynecol; 2011 Apr; 37(4):438-43. PubMed ID: 20922779
[TBL] [Abstract][Full Text] [Related]
16. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
[TBL] [Abstract][Full Text] [Related]
17. First-trimester ductus venosus velocity ratio as a marker of major cardiac defects.
Wagner P; Eberle K; Sonek J; Berg C; Gembruch U; Hoopmann M; Prodan N; Kagan KO
Ultrasound Obstet Gynecol; 2019 May; 53(5):663-668. PubMed ID: 30125415
[TBL] [Abstract][Full Text] [Related]
18. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
[TBL] [Abstract][Full Text] [Related]
19. Obstetric outcomes in pregnancies with normal nuchal translucency and abnormal ductus venosus Doppler in the first trimester ultrasonography.
Seckin KD; Karslı MF; Baser E; Yeral MI; Tasin C; Ozgu Erdinc AS; Danisman N
J Obstet Gynaecol; 2016 May; 36(4):440-3. PubMed ID: 26457755
[TBL] [Abstract][Full Text] [Related]
20. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
